MedTrace Logo

Development of an Optimal Algorithm for the Management of Patients With Retinal Pigment Epithelium Detachment in Neovascular Age-related Macular Degeneration Using Artificial Intelligence

NCT05208931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-04-13

No results posted yet for this study

Summary

The study involves the development of an algorithm for predicting anatomical and functional results of therapy with angiogenesis inhibitors in patients with retinal pigment epithelium detachments in neovascular age-related macular degeneration, based on primary optical coherence tomography of the macular zone and clinical data.

Conditions

  • Neovascular Age-related Macular Degeneration

Interventions

PROCEDURE

Anti-vascular endothelial growth factor therapy

0.05 ml anti-VEGF, intravitreal, monthly

Sponsors & Collaborators

  • The S.N. Fyodorov Eye Microsurgery State Institution

    lead OTHER_GOV

Principal Investigators

  • Viktoria Myasnikova, D.Med.Sc. · Deputy Director for Research

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-09-01
Completion
2022-09-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05208931 on ClinicalTrials.gov